Dr. Abramovitch is an Associate Professor of Psychology at the Department of Psychology at Texas State University. He is a Licensed Psychologist and Clinical Neuropsychologist, and a staff researcher at the Dept of Psychiatry at Massachusetts General Hospital (MGH).
Dr. Abramovitch received his MA in Clinical Neuropsychology (Summa Cum Laude) from the Academic College of Tel-Aviv and obtained his Ph.D. in Neuropsychology from Tel-Aviv University. Prior to joining Texas State University, Dr. Abramovitch was a Research Fellow at the Department of Psychiatry at Harvard Medical School & MGH, and taught at Harvard University and Harvard Extension School.
He has published over 50 peer-reviewed manuscripts and book chapters and currently serves on several journal editorial boards, as well as on national and international scientific conferences and grant committees. Dr. Abramovitch also serves as Associate Editor for several journals, including the Journal of Obsessive-Compulsive and Related Disorders, Frontiers Psychiatry, and the Bulletin of the Menninger Clinic.
Dr. Abramovitch received several awards including the Rothschild Family Post-Doctoral Fellowship, and was named a 2017 ‘Rising Star’ by the Association for Psychological Science (APS), awarded to early-career scholars for substantial contribution to the science of psychology. More recently, he was awarded the Presidential Distinction Award for Scholarly Activities at Texas State University.
His research interests include cognitive functions and psychopathology (particularly OCD), the impact of anxiety on cognition, behavioral impulsivity, and psychometrics. In recent years Dr. Abramovitch has been focusing on cognitive function in the context of adult and pediatric OCD, perfectionism, generalized anxiety disorders, and misophonia. More recently Dr. Abramovitch offered a transdiagnostic perspective on cognitive dysfunction across DSM disorders, coining the term the ‘C Factor’, exemplifying cognitive dysfunction as a transdiagnostic dimension across disorders. In addition, he recently developed a revision of the OCI-R (the OCI-12), and an ultra-brief OCD screening scale (the OCI-4).
